Gilead’s remdesivir has emerged as a promising early hope for treating Covid-19

Are over-the-counter painkillers as safe as they were once thought to be?

Could modelling the body be a game-changer for drug testing?

Consumer protection agencies are watching out for exploitative price gouging 

Who foots the bill for new drugs and vaccines developed during a pandemic?

A new approach could help address key issues with current anticoagulants

Finding a cure for HIV with ViiV Healthcare and UNC-Chapel Hill

Veeva vs IQVIA: whats behind the anti-competitive data lawsuit?

Could nanoparticles unlock the pharmaceutical benefits of turmeric?

Why aren’t more companies automating pharmacovigilance data capture?

Turning attention towards patient benefits with IDMP data standards implementation